• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用高效液相色谱法测定剂型中的乙酰唑胺。

Determination of acetazolamide in dosage forms by high performance liquid chromatography.

作者信息

Gomaa Z S

机构信息

Department of Chemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.

出版信息

Biomed Chromatogr. 1993 May-Jun;7(3):134-5. doi: 10.1002/bmc.1130070305.

DOI:10.1002/bmc.1130070305
PMID:8318828
Abstract

A high performance liquid chromatographic assay for the quantitation of acetazolamide in both tablet and injection form is described. Acetazolamide is extracted with 0.005 M NaOH solution containing 0.3 mg/mL sulphadiazine (internal standard). A commercially available mu-Bondapak C18 cartridge column was used for the separation together with a mobile phase made of acetonitrile, methanol and sodium acetate buffer mixture (10:2:88) (pH 4) at a flow-rate of 4 mL/min. Retention times of about 2.50 and 3.36 min were obtained for the drug and the internal standard, respectively.

摘要

本文描述了一种用于定量片剂和注射剂形式乙酰唑胺的高效液相色谱法。乙酰唑胺用含有0.3mg/mL磺胺嘧啶(内标)的0.005M氢氧化钠溶液萃取。使用市售的μ-Bondapak C18柱进行分离,流动相由乙腈、甲醇和醋酸钠缓冲液混合物(10:2:88)(pH 4)组成,流速为4mL/min。药物和内标的保留时间分别约为2.50分钟和3.36分钟。

相似文献

1
Determination of acetazolamide in dosage forms by high performance liquid chromatography.采用高效液相色谱法测定剂型中的乙酰唑胺。
Biomed Chromatogr. 1993 May-Jun;7(3):134-5. doi: 10.1002/bmc.1130070305.
2
Comparison of performance of C18 monolithic rod columns and conventional C18 particle-packed columns in liquid chromatographic determination of Estrogel and Ketoprofen gel.C18整体柱和常规C18填充柱在液相色谱法测定雌二醇凝胶和酮洛芬凝胶中的性能比较。
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):191-7. doi: 10.1016/j.jchromb.2004.09.045.
3
Development and validation of a high-performance liquid chromatographic method for the determination of buspirone in pharmaceutical preparations.一种用于测定药物制剂中丁螺环酮的高效液相色谱法的开发与验证
J Pharm Biomed Anal. 2004 Apr 1;35(1):41-50. doi: 10.1016/j.jpba.2003.12.014.
4
Simultaneous high-performance liquid chromatographic determination of atenolol and amlodipine in pharmaceutical-dosage form.同时高效液相色谱法测定药物剂型中阿替洛尔和氨氯地平的含量。
Pak J Pharm Sci. 2007 Oct;20(4):274-9.
5
Simultaneous high-performance liquid chromatographic determination of pioglitazone and metformin in pharmaceutical-dosage form.高效液相色谱法同时测定药物剂型中的吡格列酮和二甲双胍
J Chromatogr Sci. 2004 Jan;42(1):27-31.
6
High pressure liquid chromatographic determination of sulfisoxazole in pharmaceuticals and separation patterns of other sulfonamides.
J Assoc Off Anal Chem. 1981 Jul;64(4):851-4.
7
Nonaqueous reverse phase liquid chromatographic determination of vitamin D2 in multivitamin tablets, using vitamin D3 as internal standard.以维生素D3为内标,采用非水反相液相色谱法测定多种维生素片中的维生素D2。
J Assoc Off Anal Chem. 1983 Jul;66(4):939-45.
8
[Study on separation of sulfonamides by capillary high-performance liquid chromatography and electrochromatography].[毛细管高效液相色谱法和电色谱法分离磺胺类药物的研究]
Yao Xue Xue Bao. 2003 Feb;38(2):129-32.
9
Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations.用于测定药物制剂中利塞膦酸盐的反相离子对高效液相色谱法的开发与验证
Anal Chim Acta. 2007 Feb 12;584(1):153-9. doi: 10.1016/j.aca.2006.11.012. Epub 2006 Nov 11.
10
Determination of leflunomide in tablets by high performance liquid chromatography.采用高效液相色谱法测定片剂中的来氟米特。
J Pharm Biomed Anal. 2006 Jan 23;40(1):197-201. doi: 10.1016/j.jpba.2005.06.030. Epub 2005 Aug 19.

引用本文的文献

1
Validated Stability indicating Spectrophotometric Method for the Determination of Acetazolamide in Dosage Forms through Complex Formation with Palladium (II).通过与钯(II)形成配合物测定剂型中乙酰唑胺的经验证的稳定性指示分光光度法
Int J Biomed Sci. 2010 Jun;6(2):141-9.